Stepanov agreed in India: tests of the “nasal” antikovid vaccine will be carried out in Ukraine


Get real time updates directly on you device, subscribe now.

Ukraine, represented by Minister of Health Maxim Stepanov, has agreed to conduct future clinical trials in the country of a “nasal” candidate vaccine from the Indian company Bharat Biotech. The head of the Ministry of Health announced this at a briefing after returning from a trip to India.


“During the negotiations, we agreed on the readiness of Ukraine to participate in clinical trials of a new development, a new vaccine, which they produced in the form of a nasal spray or drops,” he said.

The drug was developed using the adenoviral vector technology: the same as Oxford / AstraZeneca, Sputnik-5 and others.

See also: Vaccine for Ukraine. Hospital admissions plummeted after AstraZeneca dose: UK data

ВBV154 is a drug in which a section of the coronavirus genome encoding the production of S-protein, the main irritant for the immune system, is “sewn” into the genome of a chimpanzee adenovirus (which serotype is not reported), which is completely harmless to humans. When such a GMO-adenovirus enters the body, the cells begin to produce S-protein, on which immunity is immediately “trained”. When they then meet with a real coronavirus, the body will already have an established scheme of protection against the disease.

The news is supplemented …

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.